REGULATION OF ACETYLCHOLINE-RECEPTOR ALPHA-SUBUNIT VARIANTS IN HUMAN MYASTHENIA-GRAVIS - QUANTIFICATION OF STEADY-STATE LEVELS OF MESSENGER-RNA IN MUSCLE BIOPSY USING THE POLYMERASE CHAIN-REACTION
T. Guyon et al., REGULATION OF ACETYLCHOLINE-RECEPTOR ALPHA-SUBUNIT VARIANTS IN HUMAN MYASTHENIA-GRAVIS - QUANTIFICATION OF STEADY-STATE LEVELS OF MESSENGER-RNA IN MUSCLE BIOPSY USING THE POLYMERASE CHAIN-REACTION, The Journal of clinical investigation, 94(1), 1994, pp. 16-24
Myasthenia gravis (MG) is an autoimmune disease mediated by auto-antib
odies that attack the nicotinic acetylcholine receptor (AChR). To eluc
idate the molecular mechanisms underlying the decrease in AChR levels
at the neuromuscular junction, we investigated the regulation of AChR
expression by analyzing mRNA of the two AChR alpha subunit isoforms (P
3A+ and P3A-) in muscle samples from myasthenic patients relative to c
ontrols. We applied a quantitative method based on reverse transcripti
on of total RNA followed by polymerase chain reaction (PCR), using an
internal standard we constructed by site-directed mutagenesis. An incr
eased expression of mRNA coding for the alpha subunit of the AChR isof
orms was observed in severely affected patients (P < 0.003 versus cont
rols) but not in moderately affected patients, independently of the an
ti-AChR antibody titer. Study of mRNA precursor levels indicates a hig
her expression in severely affected patients compared to controls, sug
gesting an enhanced rate of transcription of the message coding for th
e alpha subunit isoforms in these patients. We have also reported that
mRNA encoding both isoforms are expressed at an approximate 1:1 ratio
in controls and in patients. We have thus identified a new biological
parameter correlated with disease severity, and provide evidence of a
compensatory mechanism to balance the loss of AChR in human myastheni
a gravis, which is probably triggered only above a certain degree of A
ChR loss.